contributor
- Calder, Christopher Sub-Investigator - 2007
A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects with Moderate to Severe Diabetic Neuropathy and Unmeasurable Nerve Conduction Velocity, Sangamo Biosciences.
Grant
- Affiliation